These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28980185)
41. In vitro release evaluation of hydrocortisone liquisolid tablets. Spireas S; Sadu S; Grover R J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356 [TBL] [Abstract][Full Text] [Related]
42. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153 [TBL] [Abstract][Full Text] [Related]
43. Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms. Khames A Expert Opin Drug Deliv; 2013 Oct; 10(10):1335-43. PubMed ID: 23706099 [TBL] [Abstract][Full Text] [Related]
44. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
45. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534 [TBL] [Abstract][Full Text] [Related]
46. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design. Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006 [TBL] [Abstract][Full Text] [Related]
47. The Development of Self-nanoemulsifying Liquisolid Tablets to Improve the Dissolution of Simvastatin. Elkadi S; Elsamaligy S; Al-Suwayeh S; Mahmoud H AAPS PharmSciTech; 2017 Oct; 18(7):2586-2597. PubMed ID: 28236269 [TBL] [Abstract][Full Text] [Related]
48. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets. Adibkia K; Shokri J; Barzegar-Jalali M; Solduzian M; Javadzadeh Y Colloids Surf B Biointerfaces; 2014 Jan; 113():10-4. PubMed ID: 24060925 [TBL] [Abstract][Full Text] [Related]
49. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion. Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354 [TBL] [Abstract][Full Text] [Related]
50. Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies. Azharshekoufeh L; Shokri J; Barzegar-Jalali M; Javadzadeh Y Bioimpacts; 2017; 7(1):5-12. PubMed ID: 28546948 [No Abstract] [Full Text] [Related]
51. Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology. Lam M; Ghafourian T; Nokhodchi A AAPS PharmSciTech; 2019 Jun; 20(6):231. PubMed ID: 31236781 [TBL] [Abstract][Full Text] [Related]
52. Artificial neural networks (ANNs) and partial least squares (PLS) regression in the quantitative analysis of cocrystal formulations by Raman and ATR-FTIR spectroscopy. Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K J Pharm Biomed Anal; 2018 Sep; 158():214-224. PubMed ID: 29886369 [TBL] [Abstract][Full Text] [Related]
53. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410 [TBL] [Abstract][Full Text] [Related]
54. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen. Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M Drug Dev Ind Pharm; 2015; 41(9):1548-57. PubMed ID: 25308746 [TBL] [Abstract][Full Text] [Related]
55. Suitability of various excipients as carrier and coating materials for liquisolid compacts. Hentzschel CM; Sakmann A; Leopold CS Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826 [TBL] [Abstract][Full Text] [Related]
56. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Javadzadeh Y; Musaalrezaei L; Nokhodchi A Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643 [TBL] [Abstract][Full Text] [Related]
57. Furosemide - Soluplus® Solid Dispersion: Development and Characterization. Prasad R; Radhakrishnan P; Singh SK; Verma PRP Recent Pat Drug Deliv Formul; 2017; 11(3):211-220. PubMed ID: 29189186 [TBL] [Abstract][Full Text] [Related]
58. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions. Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850 [TBL] [Abstract][Full Text] [Related]
59. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897 [TBL] [Abstract][Full Text] [Related]
60. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Chavan RB; Modi SR; Bansal AK Int J Pharm; 2015 Nov; 495(1):374-384. PubMed ID: 26364711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]